Pain Disorder
Pain disorder is chronic pain experienced by a patient in one or more areas, and is thought to be caused by psychological stress. The pain is often so severe that it disables the patient from proper functioning.
Cluster Number:
Wiki Number: PW149
Diagnosis: Pain Disorder
US Patients:
World Patients:
Sex Ratio: M;F+
Age Onset: Children
Brain Area:
Symptoms: Chronic pain thought to be caused by psychological stress; after accident, during illness, after drug withdrawal – but pain continues
Progression: After the pain should be gone, it increases due to attention or benefits for it.
Causes:
Medications: transcutaneous electrical nerve stimulation, trigger-point injections, surgical ablations
Therapies: CBT-talk to retrain behaviors. Lohr’s “Calming My Pain!” DVD or Download (offered on this website) may help if used as requested.
Youtube Video: Pain and the Brain
Amazon or Library Book: When Children Feel Pain
Click the book to link or order from Amazon.
Jim Lohr’s own “Calming My Pain” can be downloaded
from the “Blue Box” on this website.
You can download this program from the “Blue Box”
in the right column of the website.
Support Group: painconnection.org; 800-910-0664
(U. S. Pain Foundation)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Longitudinal associations between subjective cognitive impairment, pain and depressive symptoms in home-dwelling older adults: Modelling within-person effectsby Miharu Nakanishi on May 18, 2024
CONCLUSIONS: A directional relationship was observed from pain to depressive symptoms. Pain reduction holds a potential benefit in the prevention of depressive symptoms, ultimately optimising the QoL of older adults.
- Saccharomyces boulardii improves clinical and paraclinical indices in overweight/obese knee osteoarthritis patients: a randomized triple-blind placebo-controlled trialby Neda Dolatkhah on May 18, 2024
CONCLUSION: Probiotic S. boulardii supplementation in patients with KOA significantly improved pain intensity, some dimensions of QoL, and inflammatory and oxidative stress biomarkers with no severe side effects.
- Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophagesby Srikanth Iyer on May 18, 2024
INTRODUCTION: Chronic pancreatitis (CP) is a persistent, recurrent, and progressive disorder that is characterized by chronic inflammation and irreversible fibrosis of the pancreas. It is associated with severe morbidity, resulting in intense abdominal pain, diabetes, exocrine and endocrine dysfunction, and an increased risk of pancreatic cancer. The etiological factors are diverse and the major risk factors include smoking, chronic alcoholism, as well as other environmental and genetic factors....
- Adverse event monitoring and reporting in pediatric neuromodulatory studies: A systematic reviewby Kalee Lodewyk on May 18, 2024
Neuromodulatory interventions are relatively novel and approaches to studying harms and tolerability have varied. Using a checklist based on guidelines from Good Clinical Practice and the Harms Extension of the CONSORT (Consolidated Standards of Reporting Trials) Statement, we identified how adverse events are measured, assessed, and reported in studies evaluating neuromodulation for the treatment of mental and neurodevelopmental disorders among children and adolescents. A systematic literature...